Horama est une société de #biotech au stade clinique développant des traitements de #genetherapy ciblant des maladies rares de la rétine #santé
Location: France, Ile-de-France, Paris
Employees: 11-50
Total raised: $22.17M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | Fund+ | fundplus.b... |
| - | Kurma Part... | kurmapartn... |
| - | Turenne Ca... | turennecap... |
| - | Omnes Capi... | omnescapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.11.2017 | Series B | $22.17M | Fund+ |
Mentions in press and media 1
| Date | Title | Description |
| 22.07.2021 | Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform | Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform |